Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed route for 6-methylphenanthridine synthesis offers mild conditions and environmental safety, ensuring reliable supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.
Patent CN106008492B reveals a palladium-free Razaxaban synthesis route offering high purity and cost reduction for pharmaceutical intermediate supply chains.
Patent CN103254075A reveals a novel synthesis for Flurbiprofen Axetil achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN118085036B enables aqueous cyclization reducing solvent waste. Offers supply chain reliability and cost reduction in peptide manufacturing for global partners.
Advanced catalytic reduction route for Rivastigmine Tartrate offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel PPA/TFAA catalyzed route for Ramosetron eliminates resolution steps, offering high purity and cost-effective manufacturing for global supply chains.
Patent CN107513048A details a high-yield synthetic route for deuterated Vortioxetine hydrobromate offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN110590616A reveals catalyst-free water-based synthesis reducing costs and enhancing supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN112661802B reveals a scalable, non-toxic route for 3'-methoxyguanosine, offering significant cost reduction and supply chain reliability for mRNA cap analog manufacturing.
Patent CN112661802B reveals a scalable synthesis of 3'-methoxyguanosine, offering cost reduction in mRNA cap analog manufacturing and reliable supply chain solutions.
Novel AGX51 preparation method improves yield and safety. Suitable for reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing.
Advanced one-pot synthesis of Pivmecillinam from 6-APA. High yield, low cost, suitable for industrial scale-up and global supply chains.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Patent CN111170958A details a green solid-acid catalyzed route for hydroxybenzomorph, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN118878537A reveals a cost-effective 4-step route for PRMT5 inhibitor intermediates, eliminating palladium catalysts and enhancing supply chain reliability for global pharmaceutical manufacturing.
Advanced synthesis of triacetyl ganciclovir via monoacetyl guanine condensation. Superior purity, reduced isomers, and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN106883238B reveals a high-yield 4-step route for alpha-azaspiro compounds, offering significant cost reduction and safety improvements for API intermediate manufacturing.